August 14, 2019
Weaponizing Biotech: How China’s Military Is Preparing for a ‘New Domain of Warfare’
Under Beijing's civil-military fusion strategy, the PLA is sponsoring research on gene editing, human performance enhancement, and more.
We may be on the verge of a brave new world indeed. Today’s advances in biotechnology and genetic engineering have exciting applications in medicine — yet also alarming implications, including for military affairs. China’s national strategy of military-civil fusion (军民融合) has highlighted biology as a priority, and the People’s Liberation Army could be at the forefront of expanding and exploiting this knowledge.
The PLA’s keen interest is reflected in strategic writings and research that argue that advances in biology are contributing to changing the form or character (形态) of conflict. For example:
- In 2010’s War for Biological Dominance (制生权战争), Guo Jiwei (郭继卫), a professor with the Third Military Medical University, emphasizes the impact of biology on future warfare.
- In 2015, then-president of the Academy of Military Medical Sciences He Fuchu (贺福初) argued that biotechnology will become the new “strategic commanding heights” of national defense, from biomaterials to “brain control” weapons. Maj. Gen. He has since become the vice president of the Academy of Military Sciences, which leads China’s military science enterprise.
- Biology is among seven “new domains of warfare” discussed in a 2017 book by Zhang Shibo (张仕波), a retired general and former president of the National Defense University, who concludes: “Modern biotechnology development is gradually showing strong signs characteristic of an offensive capability,” including the possibility that “specific ethnic genetic attacks” (特定种族基因攻击) could be employed.
- The 2017 edition of Science of Military Strategy (战略学), a textbook published by the PLA’s National Defense University that is considered to be relatively authoritative, debuted a section about biology as a domain of military struggle, similarly mentioning the potential for new kinds of biological warfare to include “specific ethnic genetic attacks.”
Read the full article in Defense One.
More from CNAS
-
The U.S. Is Losing Ground to China in Southeast Asia
Commentary
Without routine engagement, Southeast Asian countries become uneasy about U.S. commitments and tend to look elsewhere—such as to China—to fulfill their needs....
By Derek Grossman
-
Podcast
Indo-Pacific Security / Middle East Security
The Global Power Shift No One Is Talking About – And Who’s Driving ItMost people see the world as the U.S. vs. China. But the real power shift is happening elsewhere. Richard Fontaine, CEO of the Center for a New American Security and a former ...
By Richard Fontaine
-
China May Grab a Lead in the Race for Military Fusion
Commentary
This article was originally published in The Wall Street Journal. America’s top diplomat for nuclear-weapons issues, Undersecretary of State Thomas DiNanno, revealed this mont...
By David Feith
-
Commentary
Indo-Pacific Security / Energy, Economics & Security
How to Win the Economic War with ChinaTrump's approach to China has run aground, giving Beijing unprecedented advantage in the economic conflict....
By Edward Fishman & Julian Gewirtz
